HomeNEWSCompany Focus 

NEWS    Company Focus

Joint Venture signing ceremony between Eckert & Ziegler BEBIG GmbH and TCL Healthcare Equipment (Shanghai) Co., Ltd held today

Author:|Date:2019-08-01 20:07:37Hits:

August 1st, 2019, China Today, TCL Healthcare Equipment (Shanghai) Co., Ltd., part of the TCL Healthcare Group, a listed Chinese company and Eckert & Ziegler BEBIG GmbH, belonging to the Eckert & Ziegler AG, solemnly signed a joint venture contract. Both parties have concluded an agreement to develop, manufacture and distribute an HDR afterloader for the Chinese market. The joint venture will trade under TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd. and is held 51% by TCL Healthcare Equipment (Shanghai) Co., Ltd. and 49% by Eckert & Ziegler BEBIG GmbH.


Joint Venture signing ceremony between Eckert & Ziegler BEBIG GmbH and TCL Healthcare Equipment (Shanghai) Co., Ltd held today

Picture from the signing ceremony between Mr. George Chan, Chairman of TCL Healthcare Equipment (Shanghai) Co., Ltd. and Dr. Harald Hasselmann, Managing Director of Eckert & Ziegler BEBIG at Beaufort Terrace in Yuyuan Garden, Shanghai today


The signing ceremony was held in Shanghai in the presence of Mr. Cui Ze Shi, Deputy chief-secretary of the China Medical Equipment Association and Mrs. Johanna Spee, Regional Head of the German Chamber of Commerce as well as press and media representatives. 


Mr. George Chan, Chairman of TCL Healthcare Equipment (Shanghai) Co., Ltd. States: “With Eckert & Ziegler BEBIG, as a specialized brachytherapy provider standing for made in Germany quality and innovative HDR brachytherapy solutions such as integrated in-vivo dosimetry and being the first to introduce a miniaturized Co-60 source, we feel confident to enter the Chinese radiation oncology market. This together with our experience in development, production, regulatory approval and sales will be the key to the success of the joint venture. We look forward to providing a more affordable and accessible radiation oncology for China.”


The management of Eckert & Ziegler BEBIG GmbH also sees significant advantages in the joint venture with TCL Healthcare Equipment (Shanghai) Co., Ltd.: “The founding of TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd. is a further important step for Eckert & Ziegler BEBIG to enhance its position in the Chinese radiation oncology market. In the past, we have already introduced LDR prostate and ophthalmic brachytherapy products and the MultiSource afterloader system to the country. Now, with the new development and production facilities, we will be able to offer specialized and affordable HDR brachytherapy solutions for the Chinese market. The joint venture will enable us to quickly adapt to customer needs in the country and facilitates a significant competitive advantage.” States Dr. Harald Hasselmann, Managing Director of Eckert & Ziegler BEBIG GmbH.


China has more than 4.2 million new cancer cases per year and a death rate of more than 2.8 million*. Lung, breast, esophagus, rectum, cervix and prostate cancer were among the top of new cases in 2018 and present body sites for which Eckert & Ziegler BEBIG has already introduced specialized solutions. These will soon serve Chinese patients via the joint venture as well. 


*Source: https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf


About TCL Healthcare Equipment (Shanghai) Co., Ltd. (TCL Healthcare Equipment) 

TCL Healthcare Group, established in 2009, is one of the leading suppliers of healthcare diagnostic imaging products in China. In 2018, TCL Healthcare Group decided to expand into third-party imaging services. This offers an opportunity for external investment into its healthcare equipment business. In January 2019, Mr. George Chan, former president of Siemens Healthcare Greater China, conducted a management buyout for TCL Healthcare Equipment with TCL Healthcare Group remained as one of its significant shareholders. This allows further investment to drive R&D and global distribution as well as its entry into radiation oncology therapy field.


About Eckert & Ziegler BEBIG GmbH (Eckert & Ziegler BEBIG)

My partner in brachytherapy and radiation therapy
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treatment of cancer using brachytherapy. The company headquarters are in Germany, with production facilities in Germany and in the USA, as well as offices throughout Europe, Asia and the USA. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product
line. The company’s products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists. 


About HDR brachytherapy 

HDR brachytherapy allows radiation oncologists to deliver the radiation quickly, most often as an outpatient procedure. During this procedure a computer driven apparatus, called a remote afterloading device, pushes the radioactive source attached to a drive wire through transfer tubes and applicators to the treatment site. The radioactive source can be moved in millimeter increments and remain in a certain position (dwell position) for a predetermined amount of time to optimize the dose delivered. When the desired treatment dose has been achieved, the remote afterloading device automatically withdraws the radioactive source so there is no residual radiation or radioactivity. 

HDR brachytherapy has been used since the 1960s and today is applied to treat cancers in body sites such as gynecological, rectal, prostate and breast. The procedure enables an accurate and precise tumor-specific radiation dose delivery in a shorter course of treatment compared to other types of radiation treatment modalities while preserving the structure and function of the organ(s) treated and nearby. 

Contact TCL Healthcare Equipment (Shanghai) Co., Ltd.:

Crystal Chen

Operation Director




Contact Eckert & Ziegler BEBIG: 

Annica Witt
Marketing Communication Manager 





TEL:010-62968301/8302    FAX:010-62968315

『版权所有』TCL医疗核磁技术(无锡)有限公司 苏ICP备18057604号-1COPYRIGHT (C)2017 www.tclmedical.com ALL RIGHTS RESERVED